Over the past decade, Barcelona has moved firmly onto Europe's biotech map. The region ranked second among the European biotech hubs assessed by CPHI, and has built a growing base of life sciences companies and research institutions. It also attracted increasing amounts of international capital. More importantly, those once relatively disconnected pieces of the ecosystem are increasingly working together...

The investment provides WuXi AppTec’s clients with large-scale spray drying manufacturing capability, alongside the site's oral solid dose and packaging operations...

Medicines begin with a scientific idea. But between an idea in a research laboratory and a medication reaching a patient lies a long chain of work—scientific, technical, operational, and regulatory.

A mountain offers no shortcuts. The destination may be visible from the outset, but the route is rarely straightforward. There are steep sections, unexpected obstacles, changing conditions and moments when progress depends on careful steps, experience and trust in the people climbing alongside you. For Marco Glucini, Senior Business Development Manager at WuXi STA, that is also the best way to describe pharmaceutical development...

Some careers begin with a plan. Others begin with a question. For Jacob Mandell, Associate Director of Business Development at WuXi AppTec, it was the latter that quietly shaped everything that followed. By late June, he’ll be celebrating his 5th year with WuXi AppTec...

Across complex therapeutic areas, innovators are applying an expanding range of new modalities, from antibody-drug conjugates (ADCs) and bispecific antibodies to peptides, oligonucleotides, and other advanced formats. Yet as the therapeutic toolbox expands, one principle remains central: modality should follow biology...